OSR Health, Inc. (OSRH) EBITDA Margin (2024 - 2026)
OSR Health (OSRH) posted EBITDA Margin of 757.59% for Q1 2026, up 54.77% sequentially from 1674.81% in Q4 2025, and down 37431.0% YoY from N/an in Q1 2025.
OSR Health, Inc. (OSRH) EBITDA Margin (2024 - 2026) Analysis & Trends
OSR Health has reported EBITDA Margin for 3 years, with the latest figure at 757.59% in Q1 2026.
- Quarterly EBITDA Margin fell 37431.0% year-over-year to 757.59% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 726.07% (down 39173.0% YoY) and the FY2025 annual result came in at 631.01%, down 29988.0% from the prior year.
- EBITDA Margin rose to 757.59% in Q1 2026 per OSRH's latest filing, from 1674.81% in the prior quarter.
- Over five years, EBITDA Margin peaked at 176.0% in Q4 2024 and troughed at 1674.81% in Q4 2025.
- A 3-year average of 579.81% and a median of 433.36% in 2024 frame the typical range for EBITDA Margin.
- The widest YoY moves for EBITDA Margin: up 2046 bps in 2025, down 149881 bps in 2025.
- Over 3 years, EBITDA Margin stood at 176.0% in 2024, then slumped by 852 bps to 1674.81% in 2025, then jumped by 55 bps to 757.59% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 757.59%, 1674.81%, and 605.89% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -757.59% |
| Dec 31, 2025 | -1,674.81% |
| Sep 30, 2025 | -605.89% |
| Jun 30, 2025 | -460.51% |
| Mar 31, 2025 | -383.28% |
| Dec 31, 2024 | -176.00% |
| Sep 30, 2024 | -433.36% |
| Jun 30, 2024 | -364.03% |
| Mar 31, 2024 | -362.83% |